CVRX
Price
$0.70Alerts
Change
-$0.00 (-0.00%)
Updated
Nov 12, 01:18 PM (EDT)
Capitalization
23.14M
97 days until earnings call
Intraday BUY SELL Signals
XTNT
Price
$0.28Alerts
Change
+$0.01 (+3.70%)
Updated
Nov 11 closing price
Capitalization
40.6M
4 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CVRX vs XTNT

CVRX vs XTNT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CVRX vs. XTNT commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVRX is a Hold and XTNT is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CVRX with price predictions
Nov 11, 2026

CVRX's Indicator enters downward trend

The Aroon Indicator for CVRX entered a downward trend on November 11, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 212 similar instances where the Aroon Indicator formed such a pattern. In 186 of the 212 cases the stock moved lower. This puts the odds of a downward move at 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CVRX as a result. In 64 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.

The Moving Average Convergence Divergence Histogram (MACD) for CVRX turned negative on November 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 36 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +15.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where CVRX advanced for three days, in 245 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

CVRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 36 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.160) is normal, around the industry mean (4.142). P/E Ratio (-0.441) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.292) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. CVRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CVRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for XTNT with price predictions
Nov 11, 2026

XTNT's RSI Oscillator climbs out of oversold territory

The RSI Indicator for XTNT moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 27 similar instances when the indicator left oversold territory. In 26 of the 27 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for XTNT just turned positive on November 04, 2026. Looking at past instances where XTNT's MACD turned positive, the stock continued to rise in 43 of 48 cases over the following month. The odds of a continued upward trend are 90%.

Following a +7.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where XTNT advanced for three days, in 195 of 231 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

XTNT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on XTNT as a result. In 79 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XTNT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

The Aroon Indicator for XTNT entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.015) is normal, around the industry mean (4.142). P/E Ratio (-3.618) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.426) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. XTNT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XTNT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
XTNT: Fundamental Ratings
XTNT
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
79
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CVRXXTNT
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 9 days ago
83%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (CVRX: $0.70 vs. XTNT: $0.28)
Brand notoriety: CVRX and XTNT are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: CVRX: 43% vs. XTNT: 106%
Market capitalization -- CVRX: $23.14M vs. XTNT: $40.6M
CVRX [@Medical/Nursing Services] is valued at $23.14M. XTNT’s [@Medical/Nursing Services] market capitalization is $40.6M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVRX’s FA Score shows that 1 FA rating(s) are green while XTNT’s FA Score has 1 green FA rating(s).

  • CVRX’s FA Score: 1 green, 4 red.
  • XTNT’s FA Score: 1 green, 4 red.
According to our system of comparison, CVRX is a better buy in the long-term than XTNT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVRX’s TA Score shows that 4 TA indicator(s) are bullish while XTNT’s TA Score has 5 bullish TA indicator(s).

  • CVRX’s TA Score: 4 bullish, 4 bearish.
  • XTNT’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, XTNT is a better buy in the short-term than CVRX.

Price Growth

CVRX (@Medical/Nursing Services) experienced а -55.68% price change this week, while XTNT (@Medical/Nursing Services) price change was -6.11% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +5.70%. For the same industry, the average monthly price growth was -2.49%, and the average quarterly price growth was -1.73%.

Reported Earning Dates

CVRX is expected to report earnings on Feb 17, 2027.

XTNT is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Medical/Nursing Services (+5.70% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

XTNT and

Correlation & Price change

A.I.dvisor tells us that XTNT and STRRP have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XTNT and STRRP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XTNT
1D Price
Change %
XTNT100%
+1.09%
STRRP - XTNT
31%
Poorly correlated
-1.10%
CVRX - XTNT
26%
Poorly correlated
+0.70%
ACRS - XTNT
25%
Poorly correlated
+4.58%
MBOT - XTNT
24%
Poorly correlated
+5.71%
OM - XTNT
24%
Poorly correlated
-1.18%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPM1.720.08
+4.88%
Intelligent Protection Management Corp
LXEO3.070.01
+0.33%
Lexeo Therapeutics
OGCP5.06N/A
N/A
Empire State Realty OP LP
HON227.64-0.58
-0.25%
Honeywell International
PSN50.57-0.99
-1.92%
Parsons Corp